211 results
Page 3 of 11
424B5
jo3513q 9i5cmff
18 Jul 16
Prospectus supplement for primary offering
12:00am
424B5
a4m529r2jk0pbbovj7wn
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
0bkjkcqcfhpa2ron8
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
nuapmiof5k426wa
30 Nov 15
Current report (foreign)
12:00am
6-K
EX-99.1
8m39bsa6
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
v464w9t lt365g4y8jx
8 Jun 15
Business combination disclosure
12:00am
425
n4l29zq87 yfxe9
21 Apr 15
Business combination disclosure
12:00am
425
gvj58iggo4r0jnd2hqh
21 Apr 15
Business combination disclosure
12:00am
425
cw7i0tu2r 2qayjq
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
b03l93xfnqkd1hl
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
6-K
EX-99.1
rcy4flidre zo5
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
jkl9kfd7r0t
2 Mar 15
Teva Announces Sale of Sellersville, PA Facility
12:00am
6-K
EX-99.1
b75r7 gh9uwlz
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
EX-99.1
en12 dqwz
26 Nov 14
Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors
12:00am
6-K
EX-99.1
6glzyh3ovnmn3 jd
30 Oct 14
Teva Reports Third Quarter 2014 Results
12:00am
6-K
ce03h4 nj
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
hovkz2msw xmy251
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am
6-K
EX-99.1
oib3ouvts93
21 Jul 14
Live Filing
12:00am